Diversity, inclusion and racial disparities
Minority race/ethnicity are associated with more severe outcomes in OA and RA. Race/ethnicity is an important predictor of total knee (TKA) and total hip arthroplasty (THA) utilization and outcomes in the United States. Although African Americans have more symptomatic OA compared to Whites, they are more likely to delay care and present with more severe disease. They are also less likely to undergo TKA or THA, a disparity that has persisted for decades. For patients with RA, there are similar delays in seeking care and initiating DMARDs and biologics. It is important for rheumatologists to know the drivers of racial/ethnic and socioeconomic disparity in utilization of interventions, including arthroplasty or DMARDs, and it is critical to develop more effective strategies to address them. This session will review current outcomes data for RA and OA, including TKA, THA and DMARD utilization in the general population, explore racial disparities, and describe approaches to begin to address these challenges.